Stage FocusSeed, Series A, Series B+
GeographyGlobal
TypeVC
Last Activity2026
Industry Focus
Industries
BiotechMedtechAIHardware
Technical BenchStrong
Investor TypeDeepTech Purist
ExposureMostly DeepTech Investments
Bio
Panacea Capital (originally founded as Panacea Venture) is a life sciences venture capital firm founded in 2017 by James Huang, formerly Managing Partner at Kleiner Perkins China and at Vivo Ventures, with earlier operating roles at Anesiva, Tularik, GlaxoSmithKline, Bristol-Myers Squibb, and ALZA. The firm has raised three USD funds and operates from offices across Singapore, Taiwan, Shanghai, Bo...
Notable Investments
H
HiROD
Differentia BiotechSimilar Funds
Bold Capital Partners
Santa Monica, United States
Pure DeepTechBiotechAIMedtechSeedSeries A
Cambridge Innovation Capital
Cambridge, United Kingdom
Pure DeepTechBiotechQuantumSemiconductorsSeedSeries A
NS
Neva SGR
Turin, Italy
Industrial / CVCBiotechSpaceFusionSeedSeries A
UTEC
Tokyo, Japan
Pure DeepTechBiotechAIAdvanced MaterialsSeedSeries A
BV
Bioqube Ventures
Brussels, Belgium
Pure DeepTechBiotechMedtechSeedSeries A
BC
Boundary Capital
Northampton, United Kingdom
Pure DeepTechBiotechMedtechAdvanced MaterialsSeedSeries A